Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Prucalopride Market Growth 2022-2028

  • LP 4800000
  • 78 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Prucalopride will have significant change from previous year. According to our (LP Information) latest study, the global Prucalopride market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Prucalopride market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Prucalopride market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Prucalopride market, reaching US$ million by the year 2028. As for the Europe Prucalopride landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Prucalopride players cover Takeda, Johnson & Johnson, Apotex Corporation, and Jamp Pharma Corporation, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Prucalopride market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

1 mg

2 mg

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Offline Channel

Online Channel

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Takeda

Johnson & Johnson

Apotex Corporation

Jamp Pharma Corporation

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Prucalopride Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Prucalopride by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Prucalopride by Country/Region, 2017, 2022 & 2028

2.2 Prucalopride Segment by Type

2.2.1 1 mg

2.2.2 2 mg

2.3 Prucalopride Sales by Type

2.3.1 Global Prucalopride Sales Market Share by Type (2017-2022)

2.3.2 Global Prucalopride Revenue and Market Share by Type (2017-2022)

2.3.3 Global Prucalopride Sale Price by Type (2017-2022)

2.4 Prucalopride Segment by Application

2.4.1 Offline Channel

2.4.2 Online Channel

2.5 Prucalopride Sales by Application

2.5.1 Global Prucalopride Sale Market Share by Application (2017-2022)

2.5.2 Global Prucalopride Revenue and Market Share by Application (2017-2022)

2.5.3 Global Prucalopride Sale Price by Application (2017-2022)

3 Global Prucalopride by Company

3.1 Global Prucalopride Breakdown Data by Company

3.1.1 Global Prucalopride Annual Sales by Company (2020-2022)

3.1.2 Global Prucalopride Sales Market Share by Company (2020-2022)

3.2 Global Prucalopride Annual Revenue by Company (2020-2022)

3.2.1 Global Prucalopride Revenue by Company (2020-2022)

3.2.2 Global Prucalopride Revenue Market Share by Company (2020-2022)

3.3 Global Prucalopride Sale Price by Company

3.4 Key Manufacturers Prucalopride Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Prucalopride Product Location Distribution

3.4.2 Players Prucalopride Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Prucalopride by Geographic Region

4.1 World Historic Prucalopride Market Size by Geographic Region (2017-2022)

4.1.1 Global Prucalopride Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Prucalopride Annual Revenue by Geographic Region

4.2 World Historic Prucalopride Market Size by Country/Region (2017-2022)

4.2.1 Global Prucalopride Annual Sales by Country/Region (2017-2022)

4.2.2 Global Prucalopride Annual Revenue by Country/Region

4.3 Americas Prucalopride Sales Growth

4.4 APAC Prucalopride Sales Growth

4.5 Europe Prucalopride Sales Growth

4.6 Middle East & Africa Prucalopride Sales Growth

5 Americas

5.1 Americas Prucalopride Sales by Country

5.1.1 Americas Prucalopride Sales by Country (2017-2022)

5.1.2 Americas Prucalopride Revenue by Country (2017-2022)

5.2 Americas Prucalopride Sales by Type

5.3 Americas Prucalopride Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Prucalopride Sales by Region

6.1.1 APAC Prucalopride Sales by Region (2017-2022)

6.1.2 APAC Prucalopride Revenue by Region (2017-2022)

6.2 APAC Prucalopride Sales by Type

6.3 APAC Prucalopride Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Prucalopride by Country

7.1.1 Europe Prucalopride Sales by Country (2017-2022)

7.1.2 Europe Prucalopride Revenue by Country (2017-2022)

7.2 Europe Prucalopride Sales by Type

7.3 Europe Prucalopride Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Prucalopride by Country

8.1.1 Middle East & Africa Prucalopride Sales by Country (2017-2022)

8.1.2 Middle East & Africa Prucalopride Revenue by Country (2017-2022)

8.2 Middle East & Africa Prucalopride Sales by Type

8.3 Middle East & Africa Prucalopride Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Prucalopride

10.3 Manufacturing Process Analysis of Prucalopride

10.4 Industry Chain Structure of Prucalopride

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Prucalopride Distributors

11.3 Prucalopride Customer

12 World Forecast Review for Prucalopride by Geographic Region

12.1 Global Prucalopride Market Size Forecast by Region

12.1.1 Global Prucalopride Forecast by Region (2023-2028)

12.1.2 Global Prucalopride Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Prucalopride Forecast by Type

12.7 Global Prucalopride Forecast by Application

13 Key Players Analysis

13.1 Takeda

13.1.1 Takeda Company Information

13.1.2 Takeda Prucalopride Product Offered

13.1.3 Takeda Prucalopride Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Takeda Main Business Overview

13.1.5 Takeda Latest Developments

13.2 Johnson & Johnson

13.2.1 Johnson & Johnson Company Information

13.2.2 Johnson & Johnson Prucalopride Product Offered

13.2.3 Johnson & Johnson Prucalopride Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Johnson & Johnson Main Business Overview

13.2.5 Johnson & Johnson Latest Developments

13.3 Apotex Corporation

13.3.1 Apotex Corporation Company Information

13.3.2 Apotex Corporation Prucalopride Product Offered

13.3.3 Apotex Corporation Prucalopride Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Apotex Corporation Main Business Overview

13.3.5 Apotex Corporation Latest Developments

13.4 Jamp Pharma Corporation

13.4.1 Jamp Pharma Corporation Company Information

13.4.2 Jamp Pharma Corporation Prucalopride Product Offered

13.4.3 Jamp Pharma Corporation Prucalopride Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Jamp Pharma Corporation Main Business Overview

13.4.5 Jamp Pharma Corporation Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Prucalopride Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Prucalopride Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 1 mg

Table 4. Major Players of 2 mg

Table 5. Global Prucalopride Sales by Type (2017-2022) & (K Units)

Table 6. Global Prucalopride Sales Market Share by Type (2017-2022)

Table 7. Global Prucalopride Revenue by Type (2017-2022) & ($ million)

Table 8. Global Prucalopride Revenue Market Share by Type (2017-2022)

Table 9. Global Prucalopride Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Prucalopride Sales by Application (2017-2022) & (K Units)

Table 11. Global Prucalopride Sales Market Share by Application (2017-2022)

Table 12. Global Prucalopride Revenue by Application (2017-2022)

Table 13. Global Prucalopride Revenue Market Share by Application (2017-2022)

Table 14. Global Prucalopride Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Prucalopride Sales by Company (2020-2022) & (K Units)

Table 16. Global Prucalopride Sales Market Share by Company (2020-2022)

Table 17. Global Prucalopride Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Prucalopride Revenue Market Share by Company (2020-2022)

Table 19. Global Prucalopride Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Prucalopride Producing Area Distribution and Sales Area

Table 21. Players Prucalopride Products Offered

Table 22. Prucalopride Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Prucalopride Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Prucalopride Sales Market Share Geographic Region (2017-2022)

Table 27. Global Prucalopride Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Prucalopride Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Prucalopride Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Prucalopride Sales Market Share by Country/Region (2017-2022)

Table 31. Global Prucalopride Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Prucalopride Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Prucalopride Sales by Country (2017-2022) & (K Units)

Table 34. Americas Prucalopride Sales Market Share by Country (2017-2022)

Table 35. Americas Prucalopride Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Prucalopride Revenue Market Share by Country (2017-2022)

Table 37. Americas Prucalopride Sales by Type (2017-2022) & (K Units)

Table 38. Americas Prucalopride Sales Market Share by Type (2017-2022)

Table 39. Americas Prucalopride Sales by Application (2017-2022) & (K Units)

Table 40. Americas Prucalopride Sales Market Share by Application (2017-2022)

Table 41. APAC Prucalopride Sales by Region (2017-2022) & (K Units)

Table 42. APAC Prucalopride Sales Market Share by Region (2017-2022)

Table 43. APAC Prucalopride Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Prucalopride Revenue Market Share by Region (2017-2022)

Table 45. APAC Prucalopride Sales by Type (2017-2022) & (K Units)

Table 46. APAC Prucalopride Sales Market Share by Type (2017-2022)

Table 47. APAC Prucalopride Sales by Application (2017-2022) & (K Units)

Table 48. APAC Prucalopride Sales Market Share by Application (2017-2022)

Table 49. Europe Prucalopride Sales by Country (2017-2022) & (K Units)

Table 50. Europe Prucalopride Sales Market Share by Country (2017-2022)

Table 51. Europe Prucalopride Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Prucalopride Revenue Market Share by Country (2017-2022)

Table 53. Europe Prucalopride Sales by Type (2017-2022) & (K Units)

Table 54. Europe Prucalopride Sales Market Share by Type (2017-2022)

Table 55. Europe Prucalopride Sales by Application (2017-2022) & (K Units)

Table 56. Europe Prucalopride Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Prucalopride Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Prucalopride Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Prucalopride Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Prucalopride Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Prucalopride Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Prucalopride Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Prucalopride Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Prucalopride Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Prucalopride

Table 66. Key Market Challenges & Risks of Prucalopride

Table 67. Key Industry Trends of Prucalopride

Table 68. Prucalopride Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Prucalopride Distributors List

Table 71. Prucalopride Customer List

Table 72. Global Prucalopride Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Prucalopride Sales Market Forecast by Region

Table 74. Global Prucalopride Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Prucalopride Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Prucalopride Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Prucalopride Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Prucalopride Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Prucalopride Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Prucalopride Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Prucalopride Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Prucalopride Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Prucalopride Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Prucalopride Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Prucalopride Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Prucalopride Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Prucalopride Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Prucalopride Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Prucalopride Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Prucalopride Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Prucalopride Revenue Market Share Forecast by Application (2023-2028)

Table 92. Takeda Basic Information, Prucalopride Manufacturing Base, Sales Area and Its Competitors

Table 93. Takeda Prucalopride Product Offered

Table 94. Takeda Prucalopride Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Takeda Main Business

Table 96. Takeda Latest Developments

Table 97. Johnson & Johnson Basic Information, Prucalopride Manufacturing Base, Sales Area and Its Competitors

Table 98. Johnson & Johnson Prucalopride Product Offered

Table 99. Johnson & Johnson Prucalopride Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Johnson & Johnson Main Business

Table 101. Johnson & Johnson Latest Developments

Table 102. Apotex Corporation Basic Information, Prucalopride Manufacturing Base, Sales Area and Its Competitors

Table 103. Apotex Corporation Prucalopride Product Offered

Table 104. Apotex Corporation Prucalopride Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Apotex Corporation Main Business

Table 106. Apotex Corporation Latest Developments

Table 107. Jamp Pharma Corporation Basic Information, Prucalopride Manufacturing Base, Sales Area and Its Competitors

Table 108. Jamp Pharma Corporation Prucalopride Product Offered

Table 109. Jamp Pharma Corporation Prucalopride Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Jamp Pharma Corporation Main Business

Table 111. Jamp Pharma Corporation Latest Developments

List of Figures

Figure 1. Picture of Prucalopride

Figure 2. Prucalopride Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Prucalopride Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Prucalopride Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Prucalopride Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 1 mg

Figure 10. Product Picture of 2 mg

Figure 11. Global Prucalopride Sales Market Share by Type in 2021

Figure 12. Global Prucalopride Revenue Market Share by Type (2017-2022)

Figure 13. Prucalopride Consumed in Offline Channel

Figure 14. Global Prucalopride Market: Offline Channel (2017-2022) & (K Units)

Figure 15. Prucalopride Consumed in Online Channel

Figure 16. Global Prucalopride Market: Online Channel (2017-2022) & (K Units)

Figure 17. Global Prucalopride Sales Market Share by Application (2017-2022)

Figure 18. Global Prucalopride Revenue Market Share by Application in 2021

Figure 19. Prucalopride Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Prucalopride Revenue Market Share by Company in 2021

Figure 21. Global Prucalopride Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Prucalopride Revenue Market Share by Geographic Region in 2021

Figure 23. Global Prucalopride Sales Market Share by Region (2017-2022)

Figure 24. Global Prucalopride Revenue Market Share by Country/Region in 2021

Figure 25. Americas Prucalopride Sales 2017-2022 (K Units)

Figure 26. Americas Prucalopride Revenue 2017-2022 ($ Millions)

Figure 27. APAC Prucalopride Sales 2017-2022 (K Units)

Figure 28. APAC Prucalopride Revenue 2017-2022 ($ Millions)

Figure 29. Europe Prucalopride Sales 2017-2022 (K Units)

Figure 30. Europe Prucalopride Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Prucalopride Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Prucalopride Revenue 2017-2022 ($ Millions)

Figure 33. Americas Prucalopride Sales Market Share by Country in 2021

Figure 34. Americas Prucalopride Revenue Market Share by Country in 2021

Figure 35. United States Prucalopride Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Prucalopride Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Prucalopride Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Prucalopride Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Prucalopride Sales Market Share by Region in 2021

Figure 40. APAC Prucalopride Revenue Market Share by Regions in 2021

Figure 41. China Prucalopride Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Prucalopride Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Prucalopride Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Prucalopride Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Prucalopride Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Prucalopride Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Prucalopride Sales Market Share by Country in 2021

Figure 48. Europe Prucalopride Revenue Market Share by Country in 2021

Figure 49. Germany Prucalopride Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Prucalopride Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Prucalopride Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Prucalopride Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Prucalopride Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Prucalopride Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Prucalopride Revenue Market Share by Country in 2021

Figure 56. Egypt Prucalopride Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Prucalopride Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Prucalopride Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Prucalopride Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Prucalopride Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Prucalopride in 2021

Figure 62. Manufacturing Process Analysis of Prucalopride

Figure 63. Industry Chain Structure of Prucalopride

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390